The stock of SYGNIS Pharma AG is rated by worldwide leading analysts. Underneath you will find a list of current analyst ratings.
Please contact the relevant institutions in order to receive the entire content of these reports.
|Institution||Analyst / contact||Report Date||Rating|
|Landesbank Baden-Württemberg||Dr. Timo Kürschner||6th December 2012||Hold|
|Close Brothers Seydler Research||Igor Kim||7th December 2012||Hold|
As of December 2012
The research reports listed above reflect solely the opinion of the analysts who have prepared them. The reports do not in any way contain opinions, estimates, forecasts or projections of SYGNIS. SYGNIS makes the list available to visitors to its website for information purposes only. SYGNIS cannot accept any liability for the choice, up-to-datedness, completeness or accuracy of the research reports or for the content of the reports, especially for any recommendations, opinions or conclusions expressed therein.
The list itself does not constitute an invitation or recommendation to buy, hold or sell SYGNIS shares. SYGNIS shall not be responsible for any damages or loss suffered by a third party after using information published on this website.